LSC 2011 Abstract: The role of lipoxin A4 in the chronic obstructive pulmonary disease Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Anti-inflammatory lipoxin A4 is diminished in acute, severe exacerbations of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Leukotriene B4 receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects Source: Eur Respir J 2010; 35: 564-570 Year: 2010
The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Lipoxin A4 and lipoxin A4 receptor expression in induced sputum of asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 267s Year: 2007
The TLR5 agonist flagellin prevents bacteria-induced chronic obstructive pulmonary disease exacerbations in mice. Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017
Altered expression of TLR4 and of beta 2 defensin in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 213s Year: 2007
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2009; 34: 1444-1451 Year: 2009
Characterisation of endogenous IL-33 using a model of Alternaria -induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012
Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Polymorphism of the cyclo-oxygenase-2 gene protects against the development of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005
Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004
A role of prostaglandin D2 receptor, CRTH2, on bleomycin-induced pulmonary fibrosis Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008